Citigroup’s Lyell Immunopharma LYEL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $18.2K | Sell |
|
|||||
|
2025
Q1 | $63.4K | Sell |
|
|||||
|
2024
Q4 | $84.4K | Buy |
|
|||||
|
2024
Q3 | $178K | Buy |
|
|||||
|
2024
Q2 | $71.6K | Buy |
|
|||||
|
2024
Q1 | $106K | Sell |
|
|||||
|
2023
Q4 | $147K | Sell |
|
|||||
|
2023
Q3 | $285K | Buy |
|
|||||
|
2023
Q2 | $514K | Sell |
|
|||||
|
2023
Q1 | $983K | Buy |
|
|||||
|
2022
Q4 | $939K | Buy |
|
|||||
|
2022
Q3 | $1.51M | Buy |
|
|||||
|
2022
Q2 | $208K | Sell |
|
|||||
|
2022
Q1 | $210K | Sell |
|
|||||
|
2021
Q4 | $368K | Buy |
|
|||||
|
2021
Q3 | $40K | Buy |
|